Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past hour
Any time
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
33m
on MSN
Seres Therapeutics gains amid takeover speculation
Seres Therapeutics (NASDAQ:MCRB) rose 5% amid a report that Nestle (OTCPK:NSRGY) has raised its offer for the company. Nestle ...
The American Journal of Managed Care
33m
Lenacapavir Highly Effective in Preventing HIV
New data from the PURPOSE 2 trial continue to show the efficacy of lenacapavir in HIV prevention in individuals who have sex ...
BioSpace
57m
Pfizer’s TALZENNA® in Combination with XTANDI® Prolongs Overall Survival in Phase 3 TALAPRO-2 Trial
(NYSE: PFE) today announced positive topline results from the final prespecified overall survival (OS) analysis of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Files suit against accuser
How to help Milton victims
Inflation likely cooled again
Announces retirement
US warns of solar storm
Increases heart attack risk?
Walz on Electoral College
Top colleges hit with lawsuit
Meat, poultry items recalled
Judge tosses New York law
273 'noncitizens' removed
Idaho murder trial delayed
Ex-AR deputy sentenced
Rare comet in October
Speaks with Netanyahu
Jobless claims surge
Tesla robotaxi launch
Nobel Prize in literature
Ukraine meeting postponed
Georgia election board sued
Mets advance to NLCS
AZ Senate debate takeaways
Faces $3B in penalties
GSK to settle 80K lawsuits
To settle FTC charges
$273M Helene relief bill
Approves elimination of NLI
Feedback